Not recruiting yet
To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer
NCT06561646 · The First Affiliated Hospital with Nanjing Medical University · Updated 20 Aug 2024
- What is being tested
- single-port robotic-assisted nipple-sparing mastectomy and sentinel lymph node biopsy; single-port robotic-assisted nipple-sparing mastectomy and axillary lymph node dissection
- For
- Breast Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 60 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 21 Aug 2024, ends 31 Dec 2028. Registered 20 Aug 2024.
- Results
- None posted yet.
In the researchers' words
The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of breast cancer is still in the exploratory stage and needs to be further improved. This prospective, single-center, single-arm clinical study was conducted to use the abdominal endoscopic surgery system and evaluate the effectiveness and safety of the single-port robotic-assisted breast surgery in breast cancer.
Sites
- The First Affiliated Hospital with Nanjing Medical UniversityNanjing, Jiangsu, China